The Chandan Healthcare IPO is set to open for subscription on February 10, 2025, and will close on February 12, 2025. This is a Book Built Issue IPO, through which the company aims to raise approximately ₹107.36 crores. The IPO comprises a fresh issue of ₹70.79 crores and an offer for sale (OFS) of up to 22,99,936 equity shares, each having a face value of ₹10.
Chandan Healthcare IPO Price Band & Market Quota
- IPO Price Band: ₹151 to ₹159 per share
- Retail Investor Quota: 35%
- Qualified Institutional Buyers (QIB): 50%
- High Net Worth Individuals (HNI): 15%
- Listing Date: February 17, 2025 (on NSE)
- IPO Allotment Date: February 13, 2025
Chandan Healthcare Financial Performance
The company has demonstrated strong financial growth in recent years:
- Revenue Growth: ₹177.96 crores in 2024 (up from ₹137.03 crores in 2023)
- Net Profit: ₹16.36 crores in 2024 (up from ₹3.59 crores in 2023)
Chandan Healthcare IPO Date & Price Band Details
| Category | Details |
|---|---|
| IPO Open Date: | February 10, 2025 |
| IPO Close Date: | February 12, 2025 |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹151 to ₹159 Per Share |
| Issue Size: | Approx ₹107.36 Crores |
| Fresh Issue: | Approx ₹70.79 Crores |
| Offer for Sale: | Approx 22,99,936 Equity Shares |
| Issue Type: | Book Built Issue |
| IPO Listing: | NSE SME |
| Retail Quota: | Not more than 35% |
| QIB Quota: | Not more than 50% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
About Chandan Healthcare Overview
Chandan Healthcare is a leading healthcare service provider in North India, offering a wide range of diagnostic services, retail pharmacy, and hospital facilities. With a strong presence in Uttar Pradesh and Uttarakhand, Chandan Healthcare has established itself as a trusted name in the region.
Company Overview
Established in 2003, Chandan Healthcare has grown into a diversified healthcare group, providing services to millions of patients annually. The company’s offerings include:
- Diagnostic Services: A comprehensive network of state-of-the-art laboratories providing pathology and radiology services, including biochemistry, hematology, histopathology, microbiology, immunology, CT scans, X-rays, and MRIs.
- Retail Pharmacy: A chain of retail pharmacies in Uttar Pradesh, Uttarakhand, and Delhi, providing access to a wide range of medications and healthcare products.
- Hospitals: A multi-specialty hospital in Lucknow, offering advanced medical care across various disciplines.
Strengths
- Strong Geographical Presence: Chandan Healthcare has a significant presence in North India, particularly in Uttar Pradesh and Uttarakhand, with a wide network of diagnostic centers and pharmacies.
- Integrated Services: The company offers a comprehensive range of healthcare services, including diagnostics, pharmacy, and hospitals, providing a one-stop solution for patients.
- Experienced Management Team: Chandan Healthcare is led by a dedicated management team with extensive experience in the healthcare industry.
- Focus on Quality: The company is committed to providing high-quality healthcare services, with NABL accreditation for its laboratories and a focus on patient satisfaction.
Risks
- Competition: The healthcare industry is highly competitive, with the presence of other established players and new entrants.
- Regulatory Changes: Changes in healthcare regulations and policies can impact the company’s operations and profitability.
- Technological Advancements: The healthcare industry is constantly evolving with new technologies, requiring continuous investment and adaptation.
- Economic Conditions: Economic downturns can affect healthcare spending and impact the company’s revenue.
Chandan Healthcare IPO Market Lot
Investors looking to apply for the Chandan Healthcare IPO should note that the minimum lot size is 800 shares. To participate in the IPO, retail investors need to invest at least ₹1,27,200, which is the minimum application amount required.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 800 | ₹1,27,200 |
| Retail Maximum | 1 | 800 | ₹1,27,200 |
| S-HNI Minimum | 2 | 1,600 | ₹2,54,400 |
Chandan Healthcare IPO Allotment & Listing Dates
Chandan Healthcare IPO is set to open for subscription on February 10, 2025, and will close on February 12, 2025. Investors eagerly awaiting the Chandan Healthcare IPO allotment status can check it on February 13, 2025, as the allotment process will be finalized on this date. The much-anticipated Chandan Healthcare IPO listing date is scheduled for February 17, 2025, when the stock will debut on the exchange.
| Type | Date |
|---|---|
| IPO Open Date: | February 10, 2025 |
| IPO Close Date: | February 12, 2025 |
| Basis of Allotment: | February 13, 2025 |
| Refunds: | February 14, 2025 |
| Credit to Demat Account: | February 14, 2025 |
| IPO Listing Date: | February 17, 2025 |
Chandan Healthcare IPO: Promoters & Key Shareholders
The Chandan Healthcare IPO is backed by a strong promoter group, ensuring stability and growth potential. The promoters of the company include Amaranita Holdings (India) Private Limited, along with industry veterans Amar Singh, Asmita Singh, Alok Singh, Shaleen Solanki, Vijay Singh, and Vinay Lamba. Their collective experience and leadership play a crucial role in driving the company’s expansion and market presence.
Chandan Healthcare IPO Company Financial Report
Chandan Healthcare IPO has showcased impressive financial growth in recent years. The company’s revenue surged to ₹177.96 crores in 2024, marking a significant rise from ₹137.03 crores in 2023. This strong revenue growth reflects the company’s expanding market presence and operational efficiency.
Moreover, the net profit witnessed a remarkable jump, reaching ₹16.36 crores in 2024, compared to just ₹3.59 crores in 2023. This over 4x increase in profit highlights the company’s robust financial health and improved profitability.
With such strong financials, the Chandan Healthcare IPO is gaining attention from investors looking for a promising opportunity in the healthcare sector. Stay updated for more details on its price band, allotment date, and listing information.
Amount ₹ in Crores
| Period Ended | Revenue | Expense | Profit After Tax | Assets |
|---|---|---|---|---|
| 2022 | ₹119.92 | ₹120.98 | ₹1.09 | ₹81.54 |
| 2023 | ₹137.03 | ₹132.02 | ₹3.59 | ₹98.13 |
| 2024 | ₹177.96 | ₹156.50 | ₹16.36 | ₹129.17 |
| December 2024 | ₹167.99 | ₹144.58 | ₹17.42 | ₹170.06 |
Chandan Healthcare IPO Valuation – FY2024
| KPI | Values |
|---|---|
| ROE: | 47.60% |
| ROCE: | 35.04% |
| EBITDA Margin: | 14.78% |
| PAT Margin: | 9.26% |
| Debt to equity ratio: | 1.02 |
| Earning Per Share (EPS): | ₹8.14 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 39.61% |
| Net Asset Value (NAV): | ₹20.55 |
Chandan Healthcare Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
|---|---|---|---|---|---|
| Vijaya Diagnostic Ltd | 11.62 | 77.22 | 19.91% | 64.21 | 547.81 Cr. |
| Dr. Lal Pathlabs Ltd | 46.25 | 71.20 | 19.59% | 221.61 | 2,226.64 Cr. |
| Metropolis Healthcare Ltd | 24.95 | 84.79 | 11.72% | 214.01 | 1,207.71 Cr. |
Chandan Healthcare IPO: Key Objectives and Fund Utilization
The Chandan Healthcare IPO is set to drive the company’s growth by strategically expanding its diagnostic and laboratory network. The funds raised will be utilized for:
- Setting up a state-of-the-art Flagship Diagnostic Centre in Jankipuram, Lucknow, Uttar Pradesh, to enhance healthcare accessibility and diagnostic excellence.
- Establishing a Central Reference Laboratory in Ayodhya, Uttar Pradesh, ensuring advanced testing capabilities and faster diagnostics.
- Launching another Central Reference Laboratory in Ashiyana, Lucknow, Uttar Pradesh, further strengthening the company’s presence in Uttar Pradesh’s healthcare sector.
- General corporate purposes, supporting operational efficiency, business expansion, and overall growth initiatives.
With this expansion, Chandan Healthcare aims to revolutionize the diagnostic industry, offering cutting-edge technology and top-tier healthcare solutions. Stay tuned for the Chandan Healthcare IPO launch and investment opportunities!
Chandan Healthcare IPO Review
- Canara Bank
- DRChoksey FinServ
- Emkay Global
- Hem Securities
- IDBI Capital
- Marwadi Shares
- Nirmal Bang
- SBICAP Securities
- Sharekhan
- SMC Global
- Sushil Finance
- Swastika Investmart
- Ventura Securities
- Geojit
- Reliance Securities
- Capital Market
- BP Wealth
- ICICIdirect
- Choice Broking
Chandan Healthcare IPO Registrar
KFin Technologies Limited
Phone: 04067162222, 04079611000
Email: chl.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/
Chandan Healthcare IPO Lead Managers aka Merchant Bankers
- Unistone Capital Pvt Ltd
Company Address
Chandan Healthcare Limited
Biotech Park, Sector G,
Jankipuram, Kursi Road,
Lucknow-226021
Phone: +91 8429024430
Email: secretarial@chandan.co.in
Website: https://www.chandandiagnostic.com/
FAQs for Chandan Healthcare IPO
The Chandan Healthcare IPO will open for subscription on February 10, 2025, and close on February 12, 2025.
The IPO price band is set between ₹151 to ₹159 per share.
The minimum lot size is 800 shares, requiring an investment of at least ₹1,27,200 for retail investors.
Allotment Date: February 13, 2025
Listing Date: February 17, 2025 (on NSE SME)
The IPO aims to raise approximately ₹107.36 crores, comprising:
Fresh Issue: ₹70.79 crores
Offer for Sale (OFS): 22,99,936 equity shares
Investors can check their allotment status on KFin Technologies Limited’s official website.
The IPO proceeds will be used for:
Setting up a flagship diagnostic centre in Jankipuram, Lucknow
Establishing central reference laboratories in Ayodhya and Ashiyana, Lucknow
General corporate purposes
Revenue in FY 2024: ₹177.96 crores (up from ₹137.03 crores in FY 2023)
Net Profit in FY 2024: ₹16.36 crores (up from ₹3.59 crores in FY 2023)
The company is promoted by Amaranita Holdings (India) Private Limited, along with Amar Singh, Asmita Singh, Alok Singh, Shaleen Solanki, Vijay Singh, and Vinay Lamba.
Investors can apply through UPI-based online IPO applications via broker platforms like Zerodha, Upstox, Groww, and Angel One.
Disclaimer: This information is for general knowledge and informational purposes only and does not constitute financial, investment, or other professional advice.
